MZL
Clinical trials for MZL explained in plain language.
Never miss a new study
Get alerted when new MZL trials appear
Sign up with your email to follow new studies for MZL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for Hard-to-Treat lymphoma patients
Disease control Not yet recruitingThis study tests a daily oral drug called lisaftoclax in 75 adults with slow-growing lymphomas (CLL, WM, or MZL) who cannot take or have stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink or control the cancer. Treatment continues as …
Matched conditions: MZL
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 17, 2026 11:53 UTC
-
New study aims to improve First-Line lymphoma treatment
Disease control Not yet recruitingThis study looks at how well three different drug combinations (BR, R2, and OR2) work as first treatment for people with a slow-growing blood cancer called marginal zone lymphoma. About 131 adults will take part. The goal is to see which treatment best controls the cancer and has…
Matched conditions: MZL
Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 04, 2026 16:32 UTC
-
New 'Living Drug' trial targets Tough-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy, called BAFF-R CAR-T, for people with B-cell lymphomas that have come back or haven't responded to other treatments. Researchers will give the therapy at different doses to about 20 participants to check how safe …
Matched conditions: MZL
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 06, 2026 14:05 UTC